BEAR Implant Rehabilitation | Webinar with Lynn Snyder-Mackler & Carl Calabrese | Miach Orthopaedics

Physical Therapy for BEAR® Implant Patients: Reviewing the Latest Rehabilitation Protocol
Program Highlights:
• Review the enhanced rehabilitation protocol to optimize patient outcomes, released in March 2023
• Discuss how the BEAR Implant is dierent and requires a unique approach to rehabilitation
Lynn Snyder-Mackler, PT, ScD, FAPTA
University of Delaware
Alumni Distinguished Professor
Department of Physical Therapy
Newark, DE
Carl Calabrese, DPT, Cert MDT, OCS, CNPT
Victory Sports Medicine
Director of Physical Therapy
Skaneateles, NY
For more information on the BEAR Implant, visit miachortho.com...
The BEAR Implant was cleared by the U.S. Food & Drug Administration through the De Novo Pathway. It is indicated for skeletally mature patients at least 14 years of age with a complete rupture of the ACL, as confirmed by MRI. Patients must have an ACL stump attached to the tibia to construct the repair. For full product and risk information, including indications, contraindications, warnings and potential adverse effects, see the Instructions for Use at miachortho.com....
#aclsurgeryrecovery #acltear #bearimplant #ACLrestoration #physicaltherapy
About The BEAR® Implant
The Bridge-Enhanced® ACL Restoration (BEAR®) Implant is a proprietary bio-engineered implant used to facilitate healing of the torn ACL. The BEAR Implant is the first medical technology to demonstrate, with Level 1 clinical evidence, that it enables the body to heal its own torn ACL. Unlike reconstruction, which is the current standard of care, the BEAR Implant does not require a second surgical wound site to remove a healthy tendon from another part of the leg or the use of a donor tendon. The BEAR Implant acts as a bridge between the two ends of the torn ACL. The surgeon injects a small amount of the patient’s own blood into the implant and inserts it between the torn ends of the ACL in a minimally invasive procedure. The combination of the BEAR Implant and the patient’s blood enables the body to heal the torn ends of the ACL back together while maintaining the ACL’s original attachments to the femur and tibia. The BEAR Implant is resorbed by the body as the ACL heals.
The BEAR Implant was granted De Novo Approval from the U.S. Food and Drug Administration in December 2020. It is indicated for skeletally mature patients at least 14 years of age with a complete rupture of the ACL, as confirmed by MRI. Patients must have an ACL stump attached to the tibia to facilitate the restoration. Visit miachortho.com for complete product information, including Instructions for Use.
About Miach Orthopaedics, Inc.
Miach Orthopaedics, Inc. is a privately held company located in Westborough, Massachusetts, dedicated to developing bio-engineered surgical implants for connective tissue restoration. The company’s initial focus is the Bridge-Enhanced® ACL Restoration (BEAR®) Implant, which represents a paradigm shift in the treatment of ACL tears from reconstruction to restoration. The BEAR technology was pioneered by Martha Murray, M.D., founder of Miach Orthopaedics, at the Boston Children’s Hospital Department of Orthopaedic Surgery, with initial research funding provided by the NFL Players Association, Boston Children’s Hospital and the National Institutes of Health.
Follow us on our social media channels:
Facebook - / miachortho
Twitter - / miachortho
LinkedIn - / miachortho
Instagram - / bearimplant
©2023 Miach Orthopaedics. All rights reserved.
ML-1122